IFIH1 and acquired idiopathic inflammatory myopathy: It could also be used in conjunction with other measurements (e g., with anti-MDA-5 antibody) for prognostic functions in patients with IIM-ILD (20, 49–51) or to support other measurements such as PFT or HRCT.